Green tea (Camellia sinensis) has shown to exert cardioprotective benefits in observational studies. The objective of this clinical trial was to assess the effects of green tea on features of metabolic syndrome and inflammation in obese subjects.
Bibliographical noteCopyright Â© 2011 Elsevier Inc. All rights reserved.
- Biological Markers
- C-Reactive Protein
- Camellia sinensis
- Cardiovascular Diseases
- Intercellular Adhesion Molecule-1
- Metabolic Syndrome X
- Middle Aged
- Plant Extracts
- Single-Blind Method
- Vascular Cell Adhesion Molecule-1